Educating Your Patients on IMBRUVICA Treatment for CLL/SLL: A Case-Based Approach ~ 10/12/22Social Media CoordinatorOct 3, 20221 min readClick to Register Full flyer info:P0001093 (1).pdfDownload PDF • 332KB
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury
Comments